Repatha’s withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing ...

Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN) to $340 from $351 on Monday, May 4, while maintaining a ...

Amgen’s first quarter results reflected the company’s ability to outpace the impact of ongoing patent expirations and ...

Biotech company Amgen (NASDAQ:AMGN) announced better-than-expected revenue in Q1 CY2026, with sales up 5.8% year on year to ...

Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease May 5, 2026 8:00 ...

Out of 22 S&P 500 healthcare companies that reported results this week, 19 beat earnings expectations and 15 posted year-over ...

Amgen beat Wall Street expectations in Q1 2026 with $8.62 billion in revenue and $5.15 EPS, driven by strong growth in key drugs like Repatha and Evenity. Management raised full-year revenue and EPS ...

Amgen Inc () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smar ...

Question: “I am a 72-year-old man with giant-sized hands that took a beating during more than 30 years of playing football. I can type on my desktop PC’s full-size keyboard ...

I recently read in your column that you test your patient's magnesium levels when they have been on long-term proton-pump inhibitors (PPIs). When I asked my doctor ...

Can you comment on endometrial cancer? I have stage IV, and I'm in my 50s. I remain concerned about inflammatory foods. I've now embraced a macrobiotic diet, and ...

The Nautilus is a midsize, five-passenger crossover that emphasizes luxury rather than “sportiness.” This is evident as soon ...